These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 6383182)
1. Sulphonylurea in combination with insulin therapy: does it make sense? A review. Kyllästinen M Ann Clin Res; 1983; 15 Suppl 37():29-32. PubMed ID: 6383182 [TBL] [Abstract][Full Text] [Related]
2. The combination of insulin and oral hypoglycaemic drugs: a continuous challenge. Quatraro A; Giugliano D Diabete Metab; 1993; 19(2):219-24. PubMed ID: 8339852 [TBL] [Abstract][Full Text] [Related]
3. [Insulin resistance and combined therapy with sulfonylurea and insulin in non-insulin dependent diabetics]. Vozár J Vnitr Lek; 1995 Feb; 41(2):141-5. PubMed ID: 7725640 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. Johnson JL; Wolf SL; Kabadi UM Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835 [TBL] [Abstract][Full Text] [Related]
5. [Combination therapy with sulfonylurea plus insulin in "secondary failure" of type 2 diabetes]. Lotz N Ther Umsch; 1990 Jan; 47(1):49-54. PubMed ID: 2408182 [TBL] [Abstract][Full Text] [Related]
6. [The importance of concurrent therapy with insulin and sulfonylurea derivatives in type II diabetes]. Podrouzková B Vnitr Lek; 1994 May; 40(5):310-2. PubMed ID: 8023473 [TBL] [Abstract][Full Text] [Related]
9. Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone. Iwamoto Y; Kosaka K; Kuzuya T; Akanuma Y; Shigeta Y; Kaneko T Diabet Med; 1996 Apr; 13(4):365-70. PubMed ID: 9162613 [TBL] [Abstract][Full Text] [Related]
11. [The incidence of the secondary failure of sulfonylurea therapy. Epidemiological research]. Thoelke H; Ratzmann KP Dtsch Med Wochenschr; 1989 Apr; 114(15):580-3. PubMed ID: 2649348 [TBL] [Abstract][Full Text] [Related]
12. [Increased cardiovascular risk in patients with type 2 diabetes treated with sulfonylurea?]. Asvold BO; Jonsbu M; Grill V Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2560-4. PubMed ID: 11070997 [TBL] [Abstract][Full Text] [Related]
16. Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes. Bermúdez V; Cano R; Cano C; Bermúdez F; Leal E; Acosta K; Mengual E; Arraiz N; Briceño C; Gómez J; Bustamante M; Aparicio D; Cabrera M; Valdelamar L; Rodriguez M; Manuel V; Hernández R Am J Ther; 2008; 15(4):409-16. PubMed ID: 18645347 [TBL] [Abstract][Full Text] [Related]
17. Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study. Gulliford M; Latinovic R Diabetes Metab Res Rev; 2004; 20(3):239-45. PubMed ID: 15133756 [TBL] [Abstract][Full Text] [Related]
18. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy]. Dakhli S; Lamine S; Lamine F; Trabelsi N; Aouididi F; Zouaoui C; Mami FB; Achour A Tunis Med; 2007 Nov; 85(11):945-50. PubMed ID: 19166146 [TBL] [Abstract][Full Text] [Related]
19. The effect of sulphonylurea therapy on in vivo insulin sensitivity in non-insulin dependent diabetics. Ponchner M; Taylor R; Heine R; Alberti KG Horm Metab Res; 1984 Apr; 16(4):208. PubMed ID: 6373546 [No Abstract] [Full Text] [Related]
20. Combined chlorpropamide-insulin in the treatment of non-insulin-dependent diabetes mellitus with secondary failure of sulfonylurea therapy. Jiraratsatit J; Keoplung M; Chumsilp L; Chomchoengpatya P; Matayabun S J Med Assoc Thai; 1986 Dec; 69(12):627-34. PubMed ID: 3553408 [No Abstract] [Full Text] [Related] [Next] [New Search]